Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameST JUDE MEDICAL EPIC HF SYSTEM
Classification Namedefibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d)
Generic Namedual chamber implantable cardioverter defibrillator with biventricular pacing
ApplicantST. JUDE MEDICAL
PMA NumberP030054
Date Received12/19/2003
Decision Date06/30/2004
Product Code
NIK[ Registered Establishments with NIK ]
Docket Number 04M-0313
Notice Date 07/16/2004
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the st. Jude medical epic hf system and the st. Jude medical atlas + hf system. These systems are indicated for the following: the st. Jude medical epic hf and atlas + hf systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The epic hf and atlas + hf systems are also intended to provide a reduction of the symptoms of moderate to severe heart failure (nyha functional class iii or iv) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section), and have a left ventricular ejection fraction less than or equal to 35% and a prolonged qrs duration.
Approval Order Approval Order
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S004 S005 S006 
S007 S008 S009 S010 S011 S012 
S013 S014 S015 S016 S017 S018 
S019 S020 S021 S022 S023 S024 
S025 S028 S029 S030 S031 S032 
S033 S034 S035 S036 S037 S039 
S040 S041 S042 S043 S044 S045 
S046 S047 S048 S049 S050 S051 
S052 S053 S054 S055 S056 S057 
S058 S059 S060 S061 S062 S063 
S064 S065 S066 S067 S068 S069 
S070 S071 S072 S073 S074 S075 
S076 S077 S078 S079 S080 S081 
S082 S083 S084 S085 S086 S087 
S088 S089 S090 S091 S092 S093 
S094 S095 S096 S097 S098 S099 
S100 S101 S102 S103 S104 S105 
S106 S107 S108 S109 S110 S111 
S112 S113 S114 S115 S116 S117 
S118 S119 S120 S121 S122 S123 
S125 S126 S127 S128 S129 S130 
S131 S132 S133 S134 S135 S136 
S137 S138 S139 S140 S141 S142 
S143 S144 S145 S146 S147 S148 
S149 S151 S152 S153 S154 S155 
S156 S157 S158 S159 S160 S161 
S162 S163 S164 S165 S166 S167 
S168 S169 S170 S171 S172 S173 
S174 S175 S176 S177 S178 S179 
S180 S181 S182 S183 S185 S186 
S187 S188 S189 S190 S191 S192 
S193 S194 S195 S196 S197 S198 
S199 S200 S201 S202 S203 S204 
S205 S206 S207 S208 S209 S212 
S214 S215 S216 S217 S218 S220 
S221 S222 S223 S224 S225 S227 
S228 S230 S231 S232 S233 S235 
S236 S237 S239 S242 S243 S244 
S245 
-
-